United Therapeutics CorporationUTHRNASDAQ
Loading
Book Value/Share Growth AcceleratingAccelerating
Percentile Rank77
3Y CAGR-18.2%
5Y CAGR+15.2%
Year-over-Year Change
Year-over-year book value per share growth
3Y CAGR
-18.2%/yr
vs +26.0%/yr prior
5Y CAGR
+15.2%/yr
Recent deceleration
Acceleration
-44.2pp
Decelerating
Percentile
P77
Within normal range
vs 5Y Ago
2x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 6.46% |
| Q3 2025 | -5.41% |
| Q2 2025 | 4.92% |
| Q1 2025 | 6.34% |
| Q4 2024 | 4.22% |
| Q3 2024 | 6.61% |
| Q2 2024 | 12.98% |
| Q1 2024 | -10.81% |
| Q4 2023 | 4.55% |
| Q3 2023 | 5.56% |
| Q2 2023 | 4.27% |
| Q1 2023 | 5.65% |
| Q4 2022 | 11.80% |
| Q3 2022 | 4.34% |
| Q2 2022 | 2.53% |
| Q1 2022 | -0.25% |
| Q4 2021 | 2.92% |
| Q3 2021 | 4.99% |
| Q2 2021 | 5.16% |
| Q1 2021 | 1.25% |
| Q4 2020 | 3.18% |
| Q3 2020 | 5.41% |
| Q2 2020 | 4.45% |
| Q1 2020 | 6.05% |
| Q4 2019 | 2.38% |
| Q3 2019 | 5.56% |
| Q2 2019 | 9.51% |
| Q1 2019 | -16.33% |
| Q4 2018 | 2.82% |
| Q3 2018 | 3.72% |
| Q2 2018 | 8.72% |
| Q1 2018 | 13.38% |
| Q4 2017 | 1.07% |
| Q3 2017 | 20.12% |
| Q2 2017 | -14.11% |
| Q1 2017 | 5.73% |
| Q4 2016 | 3.07% |
| Q3 2016 | 4.38% |
| Q2 2016 | 8.09% |
| Q1 2016 | 8.38% |